Thanks for pointing out this transcript Bear...and thanks in particular to IMTESTY for taking the trouble to write up all those notes.  

This transcript is super useful for someone like me.  It does highlight some initial assumptions re MACE rates and expected time to complete the study.  Since they expected the trial to end in 3 years (so by November 2018) and had to continue for another 6 months, I can't help but take that as a super bullish sign. 

I know Bear will beat me up on this point (perhaps standard of care means MACE rates for all go down, including for the placebo group etc)...still 42 months instead of 36 months is an extra 1000  patient years right there.  Far more than what the 30% RRR assumption would have predicted.

All the details highlighted by each of the speaker keeps me super excited about the end resutls!